DocSym
β
Searchsearch
Search
(C62.0) Malignant neoplasm: undescended testis
More details coming soon
1 008 861 in individuals diagnosis malignant neoplasm: undescended testis confirmed
29 902 deaths with diagnosis malignant neoplasm: undescended testis
3% mortality rate associated with the disease malignant neoplasm: undescended testis
Diagnosis malignant neoplasm: undescended testis is diagnosed Prevalent in Men Only
1 008 861
Men receive the diagnosis malignant neoplasm: undescended testis
29 902 (3.0 %)Died from this diagnosis.
100
95
90
85
80
75
70
65
60
55
50
45
40
35
30
25
20
15
10
5
0
0
Women receive the diagnosis malignant neoplasm: undescended testis
0 (No mortality)Died from this diagnosis.
Risk Group for the Disease malignant neoplasm: undescended testis - Men aged 30-34 and Women aged 0
In Men diagnosis is most often set at age 0-95+
in in men, the disease manifests at any ageLess common in women the disease occurs at Age 0-95+
No Cases of the Disease Malignant neoplasm: Undescended testis identified in Men
Disease Features malignant neoplasm: undescended testis
Absence or low individual and public risk
Malignant neoplasm: undescended testis - what does this mean
Malignant neoplasm of the undescended testis (also known as cryptorchidism) occurs when one or both testes fail to descend into the scrotum during fetal development. this condition can increase the risk of developing a testicular cancer, as the testes are exposed to higher temperatures in the abdominal cavity, which can lead to genetic mutations.
What happens during the disease - malignant neoplasm: undescended testis
Malignant neoplasm of the undescended testis is caused by the failure of the testis to descend from the abdomen to the scrotum during fetal development, which can lead to an increased risk of malignancy due to the increased temperature in the abdominal cavity. this can lead to an abnormal growth of cells in the testis, which can eventually develop into a malignant neoplasm.
Clinical Pattern
More details coming soon
How does a doctor diagnose
- Physical examination to determine the presence or absence of an undescended testis
- Ultrasound imaging to assess the size, shape, and location of the testis
- CT Scan to assess the extent of the tumor
- MRI to evaluate the extent of the tumor
- Biopsy to determine the presence or absence of malignancy
- Blood tests to check for any associated abnormalities
Treatment and Medical Assistance
Main goal of the treatment: To safely remove the undescended testis and treat any associated malignancy.
- Physical examination and imaging studies to confirm the diagnosis.
- Surgery to remove the undescended testis.
- Pathology evaluation of the removed testis.
- Radiation therapy and/or chemotherapy if malignancy is found.
- Hormone therapy to restore hormone levels.
- Follow-up imaging studies to monitor for recurrence.
5 Days of Hospitalization Required
Average Time for Outpatient Care Not Established
Malignant neoplasm: undescended testis - Prevention
The best way to prevent malignant neoplasm of the undescended testis is to surgically correct the undescended testis as soon as possible. in newborns, this surgery should be done within the first few months of life. additionally, regular testicular self-exams should be practiced, as early detection is key in treating this type of cancer.